This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 (PDF - 609 KB) and Volume 2 (PDF - 1.3 MB) of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
Provides a sample treatment agreement for buprenorphine/naloxone.
Provides a sample treatment agreement for buprenorphine/Naloxone.
Provides a sample consent for treatment with buprenorphine/naloxone.
Provides a sample consent for treatment with buprenorphine/naloxone.
Presents a sample intake questionnaire for patient treatment-planning questions.
This page provides telehealth privacy and security best practices.
This web page outlines policies on substance use during pregnancy, categorizing how these policies differ from state to state.
Maternal Mortality Review Committees (MMRCs) are multi-disciplinary committees that convene at the state or local level to comprehensively review deaths of women during or within a year of pregnancy. This document summarizes substance use disorder findings in a recent review of MMRC data in 14 states.
These are state-based policies and coding guidance for telehealth services and coverage during the COVID-19 pandemic.
Email Updates